Benzyl-α-GalNAc

目录号: PL08505 纯度: ≥99%
Benzyl-α-GalNAc 是一种有效的 O-糖基化 (O-glycosylation) 抑制剂。Benzyl-α-GalNAc 能有效抑制 LX-2 细胞的增殖和活化,并抑制胶原蛋白 I/III 的表达,在肝纤维化中具有较好的研究潜力。Benzyl-α-GalNAc 还可通过抑制 O-糖基化显著增强 5-FU (HY-90006) 的抗肿瘤 (如胰腺癌) 活性。
CAS No. :3554-93-6
商品编号 规格 价格 会员价 是否有货 数量
PL08505-25mg 25mg ¥3214.00 请登录
PL08505-100mg 100mg ¥8840.00 请登录
PL08505-200mg 200mg 询价 询价
PL08505-500mg 500mg 询价 询价
PL08505-10mM*1mLinWater 10mM*1mLinWater ¥3536.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Benzyl-α-GalNAc
中文别名
苄基-2-乙酰胺基-2-脱氧-Α-D-吡喃半乳糖苷;苄基 2-乙酰氨基-2-脱氧-α-D-吡喃半乳糖苷;苄基-2-乙酰氨基-2-脱氧-α-D-吡喃半乳糖苷;苄基-2-乙酰胺基-2-脱氧-Alpha-D-吡喃半乳糖苷
英文名称
Benzyl-α-GalNAc
英文别名
a-D-Galactopyranoside,phenylmethyl 2-(acetylamino)-2-deoxy-;Benzyl 2-Acetamido-2-deoxy-α-D-galactopyranoside;16beta-Hydroxydisitoxigenin;BENZYL-2-ACETAMIDO-2-DEOXY-ALPHA-D-GALACTOPYRANOSIDE;Benzyl-α-GalNAc
Cas No.
3554-93-6
分子式
C15H21NO6
分子量
311.33
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Benzyl-α-GalNAc 是一种有效的 O-糖基化 (O-glycosylation) 抑制剂。Benzyl-α-GalNAc 能有效抑制 LX-2 细胞的增殖和活化,并抑制胶原蛋白 I/III 的表达,在肝纤维化中具有较好的研究潜力。Benzyl-α-GalNAc 还可通过抑制 O-糖基化显著增强 5-FU (HY-90006) 的抗肿瘤 (如胰腺癌) 活性。
产品详情
Benzyl-α-GalNAc 是一种有效的 O-糖基化 (O-glycosylation) 抑制剂。Benzyl-α-GalNAc 能有效抑制 LX-2 细胞的增殖和活化,并抑制胶原蛋白 I/III 的表达,在肝纤维化中具有较好的研究潜力。Benzyl-α-GalNAc 还可通过抑制 O-糖基化显著增强 5-FU (HY-90006) 的抗肿瘤 (如胰腺癌) 活性。
生物活性
Benzyl-α-GalNAc is a potent O-glycosylation inhibitor. Benzyl-α-GalNAc effectively inhibits the proliferation and activation of LX-2 cells and suppresses the expression of collagen I/III, which has good potential for investigation in liver fibrosis. Benzyl-α-GalNAc also significantly enhances the anti-tumour activity of 5-FU (HY-90006) (e.g. pancreatic cancer) by inhibiting O-glycosylation.
性状
Solid
IC50 & Target[1][2]
O-glycosylation.
体外研究(In Vitro)
Benzyl-α-GalNAc (5 mM; 72 h) inhibits O-glycosylation of mucin in SUIT-2 cells.
Benzyl-α-GalNAc (2, 4 mM; 48 h) inhibits the proliferation and activation of LX-2 cells.
Benzyl-α-GalNAc (2, 4 mM; 48 h) decreases collagen expression in LX-2 cells. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability Assay
体内研究(In Vivo)
Benzyl-α-GalNAc (1 mg/mice; tumoural injection; single daily; days 4, 6, 8 and 10 after tumour size reaches 50-70 mm) enhances the anti-tumour activity of 5-FU by inhibiting O-glycosylation in mice.
(Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours) has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Kalra AV, et al. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. Br J Cancer. 2007 Oct 8;97(7):910-8. Epub 2007 Oct 2.
[2]. Kalra AV, et al. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. Eur J Cancer. 2009 Jan;45(1):164-73.
溶解度数据
In Vitro: DMSO : 25 mg/mL (80.30 mM; ultrasonic and warming and heat to 60°C)H2O : 5 mg/mL (16.06 mM; ultrasonic and warming and heat to 60°C)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2